Thrombospondin mediates migration and potentiates platelet‐derived growth factor‐dependent migration of calf pulmonary artery smooth muscle cells
- 1 October 1993
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 157 (1) , 24-32
- https://doi.org/10.1002/jcp.1041570104
Abstract
A precipitating factor in the development of atherosclerotic lesions is the inappropriate migration and proliferation of vascular smooth muscle cells (SMC) within the intima of the vessel wall. Focusing on the role of extracellular matrix proteins in SMC migration, we have demonstrated that thrombospondin (TSP) itself is a potent modulator of SMC motility and acts to potentiate platelet‐derived growth factor (PDGF)‐mediated SMC migration as well. Migration of SMC to TSP was dose dependent. Interestingly, maximal SMC migration to TSP exceeded that to either PDGF or basic fibroblast growth factor (bFGF). The distal COOH terminus of TSP was shown to mediate SMC migration as demonstrated by complete inhibition of the response by monoclonal antibody (mAb) C6.7. Nevertheless, proteolytic fragments of TSP were not as potent as intact TSP in mediating SMC migration. Only by combining the heparin‐binding domain (HBD) with the 140 kD COOH terminal fragment was SMC migration restored to levels seen with intact TSP. Based on antibody inhibition studies, an αv‐containing integrin receptor, but not αvβ1 or αvβ3, appeared to be involved in SMC migration to TSP. The coincidental expression of PDGF and TSP at sites of vascular injury and inflammation led us to evaluate the effect of suboptimal levels of TSP on SMC responsiveness to PDGF. SMC migration in response to PDGF was enhanced nearly 60% in the presence of suboptimal concentrations of TSP. This effect was specific for PDGF and dependent on the concentration of TSP with maximal potentiation obtained between 50–100 nM TSP, concentrations tenfold lower than those necessary for SMC migration to TSP itself. mAb C6.7 completely inhibited enhancement but, as with SMC migration to TSP alone, TSP proteolytic fragments did not possess the effectiveness of the intact molecule. Additional experiments assessing SMC migration to PDGF demonstrated that PDGF stimulated SMC motility indirectly by inducing TSP synthesis. These studies suggested that TSP functions as an autocrine motility factor to modulate SMC migration, which in conjunction with PDGF could serve to aggravate and accelerate development of atherosclerotic lesions at sites of vascular injury or inflammation.Keywords
This publication has 37 references indexed in Scilit:
- Thrombospondin II: Partial cDNA sequence, chromosome location, and expression of a second member of the thrombospondin gene family in humansGenomics, 1992
- Vitronectin-induced haptotaxis of vascular smooth muscle cells in VitroExperimental Cell Research, 1991
- The stimulatory effect of PDGF on vascular smooth muscle cell migration is mediated by the induction of endogenous basic FGFBiochemical and Biophysical Research Communications, 1991
- Thrombospondin stimulates motility of human neutrophils.The Journal of cell biology, 1990
- Specific inhibition of endothelial cell proliferation by thrombospondinBiochemical and Biophysical Research Communications, 1990
- Fibrinogen is chemotactic for vascular smooth muscle cellsFEBS Letters, 1989
- Thrombospondin inhibits adhesion of endothelial cellsExperimental Cell Research, 1988
- Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferationThe Journal of cell biology, 1988
- Isolation of the thrombospondin membrane receptor.Journal of Clinical Investigation, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986